Corrine Zarwan
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
- CAR-T cell therapy research
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
Papers in
-
- Ovarian cancer diagnosis and treatment 5
- Oncology 16
- Cancer Risks and Factors 4
- Cancer Treatment and Pharmacology 3
- Cancer Immunotherapy and Biomarkers 3
- HER2/EGFR in Cancer Research 3
- Co-authors
- Sara M. TolaneyFilipa LynceGeorgia A. McCannPatrick M. DillonBruce J. DezubeShaveta VinayakAntoinette R. TanMelinda L. Telli
- Journals
- Journal of Clinical Oncology (8 papers)Gynecologic Oncology (2 papers)Annals of Oncology (2 papers)Journal of Immunotherapy (2 papers)Blood (2 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Corrine Zarwan
27 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 71
- Oncology 691
- Reproductive Medicine 203
- Cancer Research 214
- Immunology 226
- Pathology and Forensic Medicine 147
Countries citing papers authored by Corrine Zarwan
This map shows the geographic impact of Corrine Zarwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corrine Zarwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corrine Zarwan more than expected).
Fields of papers citing papers by Corrine Zarwan
This network shows the impact of papers produced by Corrine Zarwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corrine Zarwan. The network helps show where Corrine Zarwan may publish in the future.
Co-authors
The 25 scholars most cited alongside Corrine Zarwan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2022 | 12 | |
| 3 | 2021 | 75 | |
| 4 | 2020 | 11 | |
| 5 | 2020 | 3 | |
| 6 | 2019 | 16 | |
| 7 | 2019 | 57 | |
| 8 | 2018 | 122 | |
| 9 | 2018 | 1 | |
| 10 | 2018 | 66 | |
| 11 | 2017 | 3 | |
| 12 | 2016 | 6 | |
| 13 | 2013 | 48 | |
| 14 | 2012 | 8 | |
| 15 | 2011 | 3 | |
| 16 | 2010 | 33 | |
| 17 | 2010 | 23 | |
| 18 | 2010 | 3 | |
| 19 | 2009 | 3 | |
| 20 | 2008 | 41 |
About Corrine Zarwan
Corrine Zarwan is a scholar working on Reproductive Medicine, Oncology, Hematology, Cancer Research and Immunology, having authored 27 papers that have together received 1.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), Ovarian cancer diagnosis and treatment (5 papers), Cancer Risks and Factors (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Vitamin D Research Studies (3 papers), Cancer Treatment and Pharmacology (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Oncology (691 citations), Reproductive Medicine (203 citations), Cancer Research (214 citations), Immunology (226 citations) and Pathology and Forensic Medicine (147 citations). Corrine Zarwan has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Sara M. Tolaney, Filipa Lynce, Georgia A. McCann, Patrick M. Dillon, Bruce J. Dezube, Shaveta Vinayak, Antoinette R. Tan, Melinda L. Telli, Gerburg M. Wulf and John K. Erban. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology, Annals of Oncology, Journal of Immunotherapy and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.